17 Dec 2019 - Aus Tin Mining Limited (ASX:ANW) CEO, Peter Williams discusses the funding package and resumption plan for the Granville Tin Project and plans for Granville to be a foundation asset in a proposed IPO.
17 Dec 2019 - Afterpay (ASX:APT) plans to update the Afterpay US 2018 Equity Incentive Plan to offer options which give eligible participants a right to acquire common stock.
17 Dec 2019 - Air New Zealand (ASX:AIZ) reports that Former Prime Minister of New Zealand Sir John Key will retire from its Board of Directors in March.
16 Dec 2019 - It has been a huge day of trade for the ASX seeing its biggest one day gain since February. After rising at the open it continued to climb closing 1.6% higher. Nearmap (ASX:NEA) is now the biggest gainer. PolyNovo (ASX:PNV) has supplied NovoSorb BTM for dermal repair after the volcano eruption New Zealand.
16 Dec 2019 - Sienna Cancer Diagnostics Limited (ASX:SDX) Managing Director and CEO Carl Stubbings talks about the company's capital raising and co-development of tests using its SIEN-NET liquid biopsies platform technology.
16 Dec 2019 - Openpay Group (ASX:OPY) CEO & MD, Michael Eidel talks about its business model, size of the opportunity and how it differentiates itself from other buy now pay later (BNPL) providers.
16 Dec 2019 - The ASX has risen at the open following some small positive leads from Wall Street. It is now tracking 1.2% higher at noon. On Friday US and Chinese officials announced they had finally agreed to the phase one agreement after an 18-month trade war. Starpharma (ASX:SPL) has received a $4.9 million R&D tax incentive refund for the 2019 Financial Year.
16 Dec 2019 - Botanix Pharmaceuticals Limited (ASX:BOT) Founder Matthew Callahan talks about the company's Phase 2 US trial results for severe acne, plans for its Phase 3 trails, including FDA input, its Phase 2 atopic dermatitis study, and what investors can expect over the next 6 months.
16 Dec 2019 - Keytone Dairy Corporation (ASX:KTD) has received all regulatory approvals for its second manufacturing facility in New Zealand allowing it to manufacture and export formulated dairy nutritional products.
16 Dec 2019 - Australian Pharmaceutical Industries (ASX:API) has sold all of its shares in said that it had today Sigma Healthcare.
